Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments

Fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are diseases of unknown etiology presenting complex and often overlapping symptomatology. Despite promising advances on the study of miRNomes of these diseases, no validated molecular diagnostic biomarker yet exists. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Almenar-Pérez, Eloy, Sánchez-Fito, Teresa, Ovejero, Tamara, Nathanson, Lubov, Oltra, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471415/
https://www.ncbi.nlm.nih.gov/pubmed/30889846
http://dx.doi.org/10.3390/pharmaceutics11030126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471415/
https://www.ncbi.nlm.nih.gov/pubmed/30889846
http://dx.doi.org/10.3390/pharmaceutics11030126

Ejemplares similares